Jackson Hospital has added a new member to its team to proactively reduce the risk of hospital-acquired infections. The new addition, Tru-D SmartUVC, is a UV disinfection robot that kills up to 99.9 percent of harmful germs and pathogens that can live in health care environments and will be used primarily in Jackson Hospital’s surgical areas.
Tru-D SmartUVC disinfecting an operating room (Credit: Tru-D SmartUVC)
Jackson Hospital is a community not-for-profit hospital serving Montgomery and the Alabama River Region. Since 1946, Jackson Hospital has been committed to improving the health of all members of the community by providing superior, patient-centered and cost-effective care in a safe, compassionate environment.
“Jackson Hospital is a leader in providing exceptional quality of care for residents in the region,” said Joe Riley, president and CEO at Jackson Hospital. “While we already implement stringent infection prevention protocols, having Tru-D added to our standard cleaning methods will give our patients and staff peace of mind that our facility is safe and continually improving,” said Riley.
Using effective and chemical-free UVC light energy, Tru-D eradicates hard-to-kill germs and superbugs such as C. diff, MRSA, VRE, Ebola and more. Before Tru-D is activated, the room is cleaned using traditional methods. Tru-D is then brought in to begin administering a single cycle of UV energy, providing total room disinfection. Using patented Sensor360 technology, Tru-D is able to compensate for room variables such as size, shape and contents to deliver the precise, lethal dose of UVC energy needed. Through its method of calculated, measured UV dosage, Tru-D is able to disinfect in both direct and shadowed areas while removing the chance of human error in the disinfection process. After the cycle is complete, Tru-D alerts the operator via text and/or audio message that the cycle is complete and the entire room has been disinfected.
“Tru-D’s Sensor360 technology ensures total room disinfection from a single position while eliminating the chance for human error in the process,” said Chuck Dunn, CEO and President of Tru-D SmartUVC. “Due to this innovative technology, Tru-D was the only device chosen for the first-ever randomized clinical trial on UV disinfection, which was funded by the Centers for Disease Control and Prevention. Results of the Benefits of Enhanced Terminal Room Disinfection (BETR-D) study proved that Tru-D can cut transmission of four major superbugs by a cumulative 30 percent.”